NEW DELHI: Claris Lifesciences today said US-based Fresenius Kabi has filed a suit against the company to block commercialisation of its abbreviated new drug application (ANDA) for Propofol, used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results